38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Case of Galactorrhea Associated with Excitalopram

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Escitalopram is one of the most popular selective serotonin reuptake inhibitors (SSRIs) in current use as a first-line treatment for depression. Escitalopram is well-tolerated and rarely associated with serious side effects. Endocrine and reproductive side effects of serotonergic antidepressants are uncommon and galactorrhea is very rarely mentioned among SSRI-related side effects. Serotonin-enhancing antidepressants may result in a rise in prolactin levels through suppression of dopamine neurotransmission. In the present study, we report a case of hyperprolactinemic galactorrhea associated with escitalopram. A 36-year-old woman developed galactorrhea after initiation of escitalopram for depression and was found to have an elevated prolactin level. Escitalopram was discontinued with resolution of the patient's galactorrhea and normalization of her prolactin level.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: not found
          • Article: not found

          Depression: clinical, experimental, and theoretical aspects

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review.

            Hyperprolactinaemia has for decades been an inevitable and neglected side-effect of antipsychotic medication. The recent introduction of prolactin-sparing antipsychotic agents makes a re-examination of this problem timely. To review the literature on antipsychotic-induced hyperprolactinaemia and its consequences. A search was made of the Medline database (1966-2002) for key articles, supplemented by cross-referencing. During antipsychotic treatment prolactin concentrations can rise to ten times normal levels or above, and existing data indicate that 17-78% of female patients have amenorrhoea with or without galactorrhoea. Survey data, however, suggest that clinicians underestimate the prevalence of these conditions. Long-term consequences of antipsychotic-related hypo-oestrogenism require further research but are likely to include premature bone loss. Antipsychotic-induced hyperprolactinaemia should become a focus of interest in the drug treatment of psychiatric patients.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.

              Neurophysiologic findings indicate an inhibition of dopaminergic neurotransmission by selective serotonin reuptake inhibitors (SSRIs). This article highlights the relationships between changes in dopaminergic neurotrans-mission induced by SSRIs and the occurrence of certain side effects such as hyperprolactinemia, extrapyramidal symptoms, sexual and cognitive dysfunction, galactorrhea, mammary hypertrophy, and, more rarely, gynecomastia. A systematic search of the literature in English, French, and German from 1980 to 2004 was performed in MEDLINE, EMBASE, and the Cochrane Library using the keywords SSRI, dopamine, serotonin, side effects, antidepressants, citalopram, escitalopram, sertraline, paroxetine, fluoxetine, fluvoxamine, and nefazodone. References cited in all trials were searched iteratively to identify missing studies. All studies concerning inhibition of dopaminergic neurotransmission by SSRIs and SSRI-related side effects were considered. We retained 62 significant articles debating the subject. We critically reviewed the studies, depending on the methodologies (case reports, clinical reports, randomized studies), and assessed the pertinence of "dopamine-dependent" SSRI-related side effects. The analytic review of these articles suggests that some specific SSRI-related side effects be classified as dopamine-dependent. At a clinical level, it could be useful to underline dopamine-dependent characteristics of some SSRI-related side effects. This approach would allow clinicians the opportunity to search other dopamine-dependent side effects systematically. At a pharmacologic level, this approach could stimulate the development of molecules with a "corrective" function on dopamine-dependent side effects of SSRIs by facilitating dopaminergic neurotransmission.
                Bookmark

                Author and article information

                Journal
                Psychiatry Investig
                PI
                Psychiatry Investigation
                Korean Neuropsychiatric Association
                1738-3684
                1976-3026
                September 2009
                15 July 2009
                : 6
                : 3
                : 230-232
                Affiliations
                [1 ]Department of Psychiatry, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea.
                [2 ]DANA Hospital, Ansan, Korea.
                Author notes
                Correspondence: Se-Hoon Shim, MD, PhD. Department of Psychiatry, Soonchunhyang University College of Medicine, Cheonan Hospital, 23-20 Bongmyeong-dong, Cheonan 330-721, Korea. Tel +82-41-570-2280, Fax +82-41-574-7992, shshim2k@ 123456korea.com
                Article
                10.4306/pi.2009.6.3.230
                2796073
                20046401
                63852365-1b55-43bf-a36c-71b38ebe542b
                Copyright © 2009 Official Journal of Korean Neuropsychiatric Association

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 04 May 2009
                : 07 June 2009
                : 11 June 2009
                Categories
                Case Report

                Clinical Psychology & Psychiatry
                galactorrhea,escitalopram,side effect,prolactin,depression
                Clinical Psychology & Psychiatry
                galactorrhea, escitalopram, side effect, prolactin, depression

                Comments

                Comment on this article